Usana Health Sciences Inc   (USNA)
Other Ticker:  
Price: $46.5500 $-0.61 -1.293%
Day's High: $47.13 Week Perf: 0.67 %
Day's Low: $ 46.55 30 Day Perf: 0.78 %
Volume (M): 59 52 Wk High: $ 69.60
Volume (M$): $ 2,746 52 Wk Avg: $59.36
Open: $47.00 52 Wk Low: $44.01

 Market Capitalization (Millions $) 902
 Shares Outstanding (Millions) 19
 Employees 1,788
 Revenues (TTM) (Millions $) 927
 Net Income (TTM) (Millions $) 60
 Cash Flow (TTM) (Millions $) 59
 Capital Exp. (TTM) (Millions $) 10

Usana Health Sciences Inc

USANA Health Sciences, Inc., a Utah corporation, was founded in 1992 by Myron W. Wentz, Ph.D. We develop and manufacture high-quality, science-based nutritional and personal care products with a primary focus on promoting long-term health and reducing the risk of chronic degenerative disease. In so doing, we are committed to continuous product innovation and sound scientific research. We have operations in 20 markets worldwide, where we distribute and sell our products by way of direct selling. We have chosen the direct selling distribution method as we believe it is the most conducive to meeting our vision as a company, which is improving the overall health and nutrition of individuals and families around the world. Additionally, we are subject to the various laws and regulations in the United States, China, and the other markets in which we operate with respect to the products that we sell and to our method of distribution.

Our customer base comprises two types of customers: "Associates" and "Preferred Customers." Associates share in our company vision by acting as independent distributors of our products in addition to purchasing our products for their personal use. Preferred Customers purchase our products strictly for personal use and are not permitted to resell or to distribute the products.

Our products are distributed and sold in 20 markets. We have organized our markets into two geographic regions: (i) Asia Pacific, which includes three sub-regions, and (ii) Americas and Europe, as noted below.

Asia Pacific

Asia Pacific is organized into three sub-regions: Greater China, Southeast Asia Pacific, and North Asia. Markets included in each of these sub-regions are as follows:

Greater China—Hong Kong, Taiwan, and China

Southeast Asia Pacific—Australia, New Zealand, Singapore, Malaysia, the Philippines, Thailand and Indonesia(2)

North Asia—Japan and South Korea

Asia Pacific has driven our growth the last several years. Our most recent market expansions in this region include our entry into Indonesia in late 2015. Since our acquisition of BabyCare in 2010, our strategy in Asia Pacific has been centered on generating growth in China. Consequently, our growth in Asia Pacific over the last few years has been led by China, and we believe that China will continue to drive our growth in this region going forward. We also expect our business to grow in most of our other markets in this region.

Americas and Europe

Americas and Europe is our most mature region and has grown modestly on a constant currency basis over the last several years due to sales and customer growth in Canada and Mexico. We have not, however, generated sales and customer growth in the United States over the last several years. We continue to implement growth strategies in the United States and remain optimistic about our potential to generate growth in this market.

   Company Address: 3838 West Parkway Blvd. Salt Lake City 84120 UT
   Company Phone Number: 954-7100   Stock Exchange / Ticker: NYSE USNA
   USNA is expected to report next financial results on February 27, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
HLF        2.21% 
NUS   -4.91%    
• View Complete Report

Alterola Biotech Inc

Legal Cannabis Company Smashes Expectations with Operating Deficit Shrinking to $-0.47 Million in Q3 2023

Date: January 15, 2024
In the wake of major players in the legal cannabis sector revealing their substantial earnings, attention now turns to smaller businesses within the industry. Among them, ALTA, a company operating principally in the progress stage, has recently reported an operating deficit of $-0.123155 million for the second quarter of 2024. While these losses may seem concerning, a closer look suggests an optimistic trajectory for the company's future performance.
Comparing ALTA's current performance to the same period in 2023, it becomes evident that the recent management strategies have significantly curbed losses. In the July to September 2023 financial span, the company managed to reduce losses to $-0.123 million from $-0.375 million the previous quarter. This highlights the company's commitment to refining its business model and demonstrating progress in terms of financial stability.

Smart For Life Inc

Breaking News: Company's Profit Sinks to New Lows in Fiscal Q3 Ending Sep 30, 2023

The stock market can be a rollercoaster ride, with ups and downs that keep investors on their toes. However, amidst all the fluctuations, there are companies that prove to be resilient and worth considering for long-term investments. One such company is Smart For Life Inc, which has recently released its financial results for the period ending September 30, 2023.
While the numbers may initially appear disheartening, it is essential to delve deeper into the details to gain a comprehensive understanding. Smart For Life Inc has indeed reported a deficit per share of $-7.51 for the mentioned financial interval, which is a significant increase from the previous year's figure of $-0.07.

Upexi Inc

Upexi Inc's Stock Plummets, but a Whopping 136.632% Revenue Rise Shows Potential for Incredible Growth

During the past five trading days, Upexi Inc shares have experienced a decline of 0%. This brings the year to date performance to -62.04%. Despite this negative performance, there are some positive indicators for the company.
One such positive indicator is the announcement of a very solid revenue rise of 136.632% year on year to $27.35 million in the most recent fiscal period. This signifies significant growth for Upexi Inc. However, the company did report a loss of $-0.07 per share, indicating that they were not able to turn their revenue into profits.

Hero Technologies Inc

Hero Technologies Inc Surpasses Expectations with Strong Operating Income Performance in Q3 2023

Hero Technologies Inc, a prominent company in the industry, recently released its financial results for the reporting season spanning from July to September 2023. While investors did not anticipate any significant changes in revenue, there was positive news on the operating income front. This article will analyze the implications of these results on the company's future and explore potential factors impacting its financial performance.
Encouraging Operating Income:
During the mentioned period, Hero Technologies Inc recorded an operating income of $0.411683 million, which exceeded investors' expectations. This result should be viewed as promising, especially when compared to the operating income of $0.167229 million during the same period the year before. This improvement in operating income also garnered affirmation from most analysts, revealing growing confidence in the company's potential.

Electronic Servitor Publication Network Inc

The Legal Cannabis Company Boasts Impressive Revenue of $0.0225 Million ? Breaking New Ground in the Industry

The stock market is a constantly evolving arena, influenced by various factors including company performance, economic trends, and investor sentiment. In the third quarter of 2023 earnings season, Electronic Servitor Publication Network Inc (ESPN) faced significant challenges with a net shortfall of $-0.408 million, surpassing last year's $-0.086 million deficit. In this article, we delve into the implications of these financial results and what they mean for investors.
Declining Revenue and Profitability
Throughout the third quarter of the 2023 earnings season, ESPN disclosed a revenue of $0.0225 million. This figure indicates a considerable decline in revenue compared to previous periods. The decrease in revenue can be attributed to various factors, such as changes in market demand, customer behavior, or internal operational issues.


Usana Health Sciences Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com